The capital infusion, completed through a combination of primary and secondary transactions from Panthera, positions the national security-focused AI company for an initial public offering (IPO) and will accelerate its expansion into international markets, the New Delhi-headquartered firm said in a statement on Friday.

The capital infusion, completed through a combination of primary and secondary transactions from Panthera, positions the national security-focused AI company for an initial public…

Innefu Labs will utilise this funding round for global expansion and R&D. It is also looking at a potential IPO.